Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

EVRY ASA: Invitation to presentation of the third quarter results for 2018 on Tuesday 30 October

EVRY ASA will present its third quarter results of 2018 on Tuesday, 30 October 2018. The presentation will take place at EVRYs headquarter at Fornebu at 8:00 CET. · Date: 30 October 2018 · Time: 8:00 CET · Location: Snarøyveien 30, 1360 Fornebu Pre-registration is not required. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast on www.evry.com or followed by telephone at 08:00 CET. Link to webcast and dial-in details will be updated on the company’s website in due time. A replay will be available on www.evry.com soon

2cureX announces CE-IVD marking of its IndiTreat test

2cureX AB (“2cureX”), a leading company in conducting individual treatment design of cancer patients, is pleased to announce the receival of CE-IVD Marking of its product IndiTreat®, which is constructed to tailor individual treatments for colorectal cancer patients. The CE-IVD marking entitles 2cureX the right to sell IndiTreat® tests in Europe.Ole Thastrup, Chief Executive Officer of 2cureX, commented, “The CE-IVD marking of IndiTreat® is a major milestone for 2cureX. Our strong patent portfolio, the CE-IVD marking and our (positive) ongoing multinational clinical trials puts 2cureX in a

Triton has signed an agreement to acquire a majority stake in Norres Group

Frankfurt / Gelsenkirchen (Germany), 9 October 2018 – The Smaller Mid-Cap Fund advised by Triton ("Triton") has signed an agreement to acquire a majority stake in NORRES Group (NORRES), one of Europe’s market leading manufacturer of plastic industrial hoses headquartered in Gelsenkirchen, Germany. Current owner and CEO, Burkhard Mollen, will retain his management position and co-invest alongside Triton. Terms of the acquisition were not disclosed. "We want to support NORRES by investing in accelerated growth and continuous internationalisation of the company. We look forward to working

Financial calendar 2018/2019

Changes to the financial calendar: · The fourth quarter results on 7 February will be extended to include a status update on the strategy and financial targets presented at the capital markets day in 2017. · The ex-dividend date is set to 2 May. 201825 October Q3 2018 20197 February Q4 2018 (extended)7 March Annual report 201830 April Annual general meeting2 May Ex-dividend date3 May Q1 2019as of 10 May Distribution of dividends11 July Q2 201924 October Q3 201920 November Capital markets day

BerGenBio to present interim phase II clinical, preclinical and biomarker data with selective AXL inhibitor bemcentinib at ESMO

Bergen, Norway, 9 October 2018 - BerGenBio ASA (OSE:BGBIO) announces that the company and its collaborators will present interim clinical and biomarker data from its Phase II clinical programme with bemcentinib (BGB324), a first-in-class highly selective oral AXL inhibitor at the ESMO 2018 Congress in Munich (19 - 23 October 2018).Pre-clinical data on the role of AXL inhibition in Myelodysplastic Syndrome (MDS) will also be presented. Details of the presentations are below.  The posters will be made available at www.bergenbio.com in the Investors / Presentations section at the time of

Recipharm releases first serialised products to Europe

Recipharm, a leading contract development and manufacturing organisation (CDMO), has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden. In 2016 Recipharm committed to invest 40 million euros in preparing its facilities for the European Falsified Medicines Directive (EU FMD). The release of its first batch of serialised medicine to the European market is a significant milestone in the CDMO's journey towards compliance with the new regulation. Recipharm’s other facilities across Europe will also be ready to release fully

Q3 2018 conference call invitation

MTG will publish its financial results for the third quarter of 2018 at 07:30 CET on Tuesday 23 October and will hold a conference call at 09:00 CET on the same day. The call will be hosted by Jørgen Madsen Lindemann (President & CEO), Anders Jensen (NENT Group President & CEO) and Maria Redin (CFO).To participate, please dial: Sweden: +46 (0)8 5033 6574 UK: +44 (0)330 336 9105 US: +1 323-794-2093 The access pin code for the call is: 4428237 To ensure that the conference call starts on time, please dial in 5-10 minutes before the scheduled start time. The conference call

Wärtsilä’s Interim Report January-September 2018 to be published 23 October 2018 at 8.30 a.m. local time

Wärtsilä Corporation, Press release, 9 October 2018 at 10.00 a.m. EESTWärtsilä Corporation will publish its Interim Report for the period January-September 2018 on Tuesday 23 October 2018 at 8.30 a.m. Finnish time. The report will be available in pdf-format and in a web-based report system at www.wartsilareports.com, as well as on the company website at www.wartsila.com after publishing. An analyst and press conference will be held on the same date, Tuesday 23 October 2018, at 10.00 a.m. Finnish time (8.00 a.m. UK time), at the Wärtsilä headquarters in Helsinki, Finland. The combined web-

Harnessing the wind at sea

Offshore wind power is one of the most promising sources of renewable energy and floating wind farms are in particular an area of growing interest. This is because they have the potential to significantly increase the sea area available for offshore wind farms, especially in countries with limited shallow waters, such as Japan. Floating wind farms can be located further offshore, reducing the eyesore potential for communities[i] , whilst enabling them to reach stronger and more regular winds[ii] .   [i]  Laskow, Sarah (13 September 2011). "

Invitation to media and analyst briefings for Ericsson Q3 2018 report

· Report to be released at approximately 07:30 CEST on October 18, 2018 · Press briefing at Ericsson Studio with live video webcast starts at 09:00 CEST · Conference call for analysts, investors and journalists starts at 14:00 CESTEricsson's (NASDAQ: ERIC) financial report for the third quarter of 2018 will be published at approximately 07:30 CEST on October 18, 2018. The company will issue a press release with the complete financial report attached, including tables, in PDF format. Following publication of the press release, the financial report will be available on Ericsson's

Peab receives contract for ground reinforcement in Spånga

Peab has been commissioned to reinforce the ground in city block Tora, which is the first stage of street work in Bromstensstaden in Spånga. The customer is the City of Stockholm and the contract is worth SEK 116 million.Bromstensstaden is located in northwest Stockholm and there are plans for housing and services in the area. The ground reinforcement project includes soil remediation, provisional rerouting of water, storm water and sewage as well as reinforcing the soil with lime cement pillars in preparation for future construction. Work begins in October 2018 and will continue

Invitation to conference call Interim report January 1 – September 30, 2018

Byggmax interim report for the third quarter 2018 will be published on Thursday October 18, at approximately 08.00 AM. A teleconference will be held on the same day, in English, at 10.30 AM.Byggmax CEO Mattias Ankarberg and CFO Pernilla Walfridsson will present the results for the third quarter 2018 and answer questions.Presentation material will be available from 08.30 AM on October 18 at www.byggmax.se  under Financial Information / Financial reports.To join the conference call the following numbers: from Sweden+ 46 (0)8-566 426 51, from United Kingdom+44 (0)

Itiviti introduces packaged FX trading solution

-       Itiviti FX combines rich out-of-the-box FX trading capabilities with flexible customization options. -       Enables technology consolidation and cross-asset trading strategies. -       Designed to fit into existing trading infrastructure. Stockholm, Sweden, October 9, 2018 – Itiviti, the leading global provider of multi-asset trading technology and financial infrastructure, today introduced Itiviti FX, a comprehensive foreign exchange trading solution built for today’s dynamic FX market landscape and designed for compliance with the latest regulatory requirements including

Neste welcomes Norway’s leadership in reducing emissions from aviation

Neste Corporation, News, 9 October 2018 at 10 am. (EET) The Norwegian government announced on 4th October, that it will introduce a 0.5% biofuel blending mandate for aviation. This is the first time in the world, when biofuel is an essential element in the aviation fuel. "I want to congratulate Norway - their announcement marks a groundbreaking milestone in sustainable aviation. We need forerunners and bold countries, since European regulation seems to have inadequate support to sustainable growth in aviation. The signal Norway's regulation sends to other countries and

Oblique Therapeutics present tumor growth inhibition and Treg-lowering data for OT-1096 in humanized mouse TNBC model at oncology congress ESMO

Gothenburg, 09 Oct 2018 – Oblique Therapeutics, a biotech focused on new medicines for severe diseases with large unmet medical needs, today announced that it will present new promising preclinical data for the drug candidate OT-1096 in triple-negative breast cancer (TNBC) at the largest oncology congress in Europe, the European Society for Medical Oncology (ESMO), held 19-23 October in Munich, Germany.The new data of the first-in-class anti-cancer agent OT-1096 shows promising preliminary results with improved tumor growth inhibition compared to pembrolizumab, one of the blockbuster drugs

ABB expands manufacturing footprint in Indonesia

New gas-insulated switchgear facility to address increased demand for reliable power supplyABB inaugurated a new high-voltage gas-insulated switchgear (GIS) manufacturing facility in Tangerang, on the outskirts of Indonesia’s capital, Jakarta. The unit is the fourth manufacturing facility that ABB has set up in the country during the last three years as part of a $30 million investment plan. The other units manufacture high-voltage air-insulated switchgear, low-voltage, and medium-voltage switchgear. Indonesia, the fourth most populous country in the world, is the largest economy in

DreamHack in partnership with the Danish Superliga and Discovery Networks Denmark bringing top flight Danish football clubs to compete in national FIFA leaguea

Starting November 5, 2019, the best football clubs in Denmark will be competing on both the physical and virtual football pitch. In a groundbreaking national league, coined eSuperliga, teams from all Danish Superliga clubs will compete in EA SPORTS FIFA 19 as part of the Official League Qualifying events in the EA SPORTS FIFA 19 Global Series. The league will air on live tv and streaming, as the partners in the project aim to bring Danish esports to the next level and to new audiences. Through a unique partnership between the broadcaster Discovery Networks Denmark, the best

Handheld announces free MaxGo Android apps for staging and security

[Lidköping, Sweden, October 9, 2018.] Handheld Group , a leading supplier of rugged mobile computers, today announced the release of MaxGo, a suite of Android apps that allows easy configuration of staging and security settings. MaxGo apps are available at no cost for all Handheld Android rugged computer users. MaxGo software apps are designed to facilitate an even easier, safer experience for Handheld customers and their clients using rugged Android devices. This growing suite of

Minesto generates electricity for the first time with commercial-scale unit

Marine energy developer Minesto has achieved initial electricity generation with its first commercial-scale marine energy kite during the commissioning program of the company’s ground-breaking low-flow tidal energy project in Wales.“We are entering a new era of renewable energy generation and Minesto is at the forefront”, said Minesto’s CEO Dr Martin Edlund. “The achievements in Wales over the last few months makes us confident that our unique technology can operate in low-flow tidal streams and ocean currents, offering predictability and reliability to the energy mix.” The first utility-

Ziccum AB (publ) share issue oversubscribed before listing on Spotlight

STOCKHOLM, SWEDEN 9 October. On October 3, 2018, the subscription period for Ziccum's new issue of units was completed, prior to its planned listing on Spotlight. The new issue of 15.8 MSEK was subscribed to approximately 52.7 MSEK including subscription commitments, a subscription ratio of approximately 334%. Ziccum will therefore receive a total of 15.8 MSEK before issue costs of approx. 1 MSEK, while increasing the number of shareholders to approximately 1000. Settlement notes for units subscribed without preference under the new terms and conditions was issued on October 8, 2018.CEO

Ziccum AB (publ) share issue oversubscribed before listing on Spotlight

STOCKHOLM, SWEDEN 9 October: On October 3, 2018, the subscription period for Ziccum's new issue of units was completed, prior to its planned listing on Spotlight. The new issue of 15.8 MSEK was subscribed to approximately 52.7 MSEK including subscription commitments, a subscription ratio of approximately 334%. Ziccum will therefore receive a total of 15.8 MSEK before issue costs of approx. 1 MSEK, while increasing the number of shareholders to approximately 1000. Settlement notes for units subscribed without preference under the new terms and conditions was issued on October 8, 2018.CEO

Panion prepares for USA

Panion Animal Health AB develops a novel treatment for epilepsy in dogs and targets the American market first. In week 43, 2018, Panion is invited to a meeting with the USFDA in Washington DC where the development product will be presented for authority reviewers from both FDA and USDA. From Panion, three persons will participate in person; regulatory FDA-expert Dave Petrick, Director of Business development Carlos N. Velez, and CEO, DVM Anja Holm. In addition, the FDA project manager has accepted to establish a telephone connection to two of Panion’s scientific experts, so they can listen

Cantargia presents clinical data from its ongoing CANFOUR trial at ESMO

Cantargia AB (publ) today announced that interim results from its clinical Phase I/II trial of lead candidate CAN04 (nidanilimab) will be presented in a poster presentation at the ESMO Congress 2018 in Munich, Germany, on October 20, 2018.The poster presentation – with the title A first-in-class, first-in-human phase I/IIa trial of CAN04, targeting Interleukin-1 Receptor Accessory Protein (IL1RAP), in patients with solid tumors­ – will be given by the coordinating investigator Professor Ahmad Awada, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. The poster is

There are no items matching the current filter
There are no more items matching the current filter
Back to top